Sonoma Pharmaceuticals, Inc.
SNOA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$776 | -$1,241 | -$928 | -$610 |
| Dep. & Amort. | $31 | $36 | $33 | $35 |
| Deferred Tax | $188 | $93 | -$19 | $66 |
| Stock-Based Comp. | $90 | $57 | $13 | $14 |
| Change in WC | $198 | -$512 | $1,466 | $904 |
| Other Non-Cash | $174 | -$448 | $0 | -$55 |
| Operating Cash Flow | -$95 | -$2,015 | $565 | $354 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$47 | -$106 | -$2 | -$26 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$47 | -$106 | -$2 | -$26 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$81 | -$81 | -$82 | -$122 |
| Stock Issued | $0 | $23 | $790 | $1,541 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $323 | $0 | $1 | $25 |
| Financing Cash Flow | $242 | -$58 | $708 | $1,444 |
| Forex Effect | $38 | $410 | -$113 | -$283 |
| Net Chg. in Cash | $138 | -$1,769 | $1,158 | $1,489 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,236 | $5,374 | $4,078 | $2,589 |
| End Cash | $5,374 | $3,605 | $5,236 | $4,078 |
| Free Cash Flow | -$142 | -$2,121 | $563 | $328 |